title: Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage.
abstract: 3,4-Methylenedioxymetamphetamine ("ecstasy") has previously been reported to cause an acute hepatitis that may progress to liver failure. We present the first recorded case of ecstasy-induced accelerated hepatic fibrosis.
authors.affiliation: Department of Medicine, Bristol Royal Infirmary, England.
authors.forename: S I
authors.initials: SI
authors.lastname: Khakoo
authors.forename: C J
authors.initials: CJ
authors.lastname: Coles
authors.forename: J S
authors.initials: JS
authors.lastname: Armstrong
authors.forename: R E
authors.initials: RE
authors.lastname: Barry
mesh_terms: D000328:Adult; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008103:Liver Cirrhosis / Q000139:chemically induced* / Q000473:pathology; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*
chemical_list: D018817:N-Methyl-3,4-methylenedioxyamphetamine